Janumet, a diabetes drug that combines metformin and sitagliptin, has been associated with pancreatitis, a known risk factor for pancreatic cancer. New research published in the medical journal Gastroenterology found that diabetics using Janumet or Januvia had close to a threefold increased risk of being diagnosed with pancreatic cancer compared to patients taking other drugs. Janumet pancreatic cancer symptoms may include abdominal pain, bloating, nausea, diarrhea, and elevated blood sugars.
Free Confidential Case Lawsuit Evaluation: If you or a loved one has been diagnosed with pancreatic cancer after taking Janumet, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Janumet and we can help.
How Can Janumet Cause Pancreatic Cancer?
Research has indicated that diabetics taking Janumet face an increased risk of being diagnosed with acute pancreatitis, necrotizing pancreatitis, or hemorrhagic pancreatitis, diseases that are precursors to full-blown pancreatic cancer. A 2011 study published in Gastroenterology found a sixfold increase in pancreatitis – as well as a 2.7-fold increase in pancreatic cancer – in people using Janumet or Januvia compared to diabetics using other medications. The Gastroenterology study added to previous research published in a 2009 issue of Diabetes, which identified an increase in pancreatitis in rats whose GLP-1 levels were raised.
Pancreatic Cancer Overview
Janumet pancreatic cancer is a cancer of the pancreas, a large organ that manufactures and releases enzymes into the intestines that help the body’s digestive processes. Pancreatic cancer begins when abnormal cell growth occurs in the pancreas. Rather than turning into normal pancreas tissue, these abnormal cells continue multiplying and form tumors that can affect the main functions of the pancreas.
Symptoms of Janumet-Induced Pancreatic Cancer
In the initial stages of pancreatic cancer, a tumor in the pancreas may grow without any noticeable signs or symptoms. This means that the disease is often in its later stages when it is finally diagnosed. Signs and symptoms of Janumet pancreatic cancer may include:
- dark urine
- clay-colored stools
- loss of appetite
- weight loss
- pain or discomfort in the upper part of the belly or abdomen
Additional pancreatic cancer symptoms may include:
- back pain
- blood clots
Treatment & Outlook (Prognosis)
Treatment for patients with pancreatic cancer depends on the stage and location of the tumor(s), as well as the individual’s age, health and personal preferences. The fundamental goal of pancreatic cancer treatment is to eliminate the disease, if possible. When this isn’t possible, treatment shifts to preventing the cancer from growing to other parts of the body and causing more harm than it already has. In later stages where treatment is no longer effective, the doctor may recommend palliative care to make the patient as comfortable as possible.
Each year in the U.S., over 30,000 people are diagnosed with pancreatic cancer. In Europe, over 60,000 annual diagnoses of the disease are made. Because pancreatic cancer is usually diagnosed in its later stages, the survival rate after five years is less than 5%.
Click here to read more about Janumet pancreatic cancer from Diabetes Daily.
Do I Have a Janumet Pancreatic Cancer Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Janumet lawsuits. We are handling individual litigation nationwide and currently accepting new Janumet pancreatic cancer cases in all 50 states.
Free Janumet Pancreatic Cancer Lawsuit Evaluation: If you or a loved one has been diagnosed with pancreatic cancer after taking Janumet, you should contact our law firm immediately. You may be entitled to compensation by filing a Janumet suit and we can help.